In lung adenocarcinoma, PLK1/2/3 promoters had a lower level in primary tumour than those in normal tissue (Figure 6A‐C), and PLK4 promoter showed no significant alteration between normal and tumour primary (Figure 6D). This evidence concerns the gene PLK4 and lung adenocarcinoma.